ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................JBDM Ver 0.1.59 (03 Mar 2017) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification2824108CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120170712W173deBibliographieenBibliographyfrBibliographieEP13847102.4201303062014100620160527zhenen20121005529820120306CN2017071220172820150114201503201704192017162016101420170712201728C07H 15/252 20060101AFI20150721BHEP C07H 19/044 20060101ALI20150721BHEP A61K 31/7056 20060101ALI20150721BHEP A61P 35/00 20060101ALI20150721BHEP deTETRACYCLISCHE ANTHRACHINONDERIVATEenTETRACYCLIC ANTHRAQUINONE DERIVATIVESfrDÉRIVÉS D'ANTHRAQUINONE TÉTRACYCLIQUEWO-A1-2009/099741CN-A- 101 555 264JÖRG B. ENGEL ET AL: "Targeted Therapy of Breast and Gynecological Cancers with Cytotoxic Analogues of Peptide Hormones", MOLECULAR PHARMACEUTICS, vol. 4, no. 5, 1 October 2007 (2007-10-01) , pages 652-658, XP055203726, ISSN: 1543-8384, DOI: 10.1021/mp070051420150727ZHANG, Hesheng31-101 Xiao Yuan Xin Cun TEDATianjin 300457CNHUO, Aihong31-101 Xiao Yuan Xin Cun TEDATianjin 300457CNLI, Zhenzhong31-101 Xiao Yuan Xin Cun TEDATianjin 300457CNTIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO., LTD.101659876MKS/FP7066848No. 3 Workshop Culture Center Phase 2 2 Jianfu RoadXiqing Economic-Technological Development Area Tianjin 300385CNSmith, Matthewet al101256824Mewburn Ellis LLP City Tower 40 Basinghall StreetLondon EC2V 5DEGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRCN201300023320130306zhWO20140597402014042420141720150114201503